Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2023 Nov;43(11):2343-2345.
doi: 10.1111/liv.15740.

miR-21p-5p coordinates biological pathways to promote MASLD progression

Affiliations
Editorial

miR-21p-5p coordinates biological pathways to promote MASLD progression

Patricia Aspichueta et al. Liver Int. 2023 Nov.
No abstract available

Keywords: PPARα; hepatocellular carcinoma (HCC); metabolic dysfunction-associated steatohepatitis (MASH); metabolic dysfunction-associated steatotic liver disease (MASLD); miR-21-5p.

PubMed Disclaimer

Comment on

  • miR-21-5p promotes NASH-related hepatocarcinogenesis.
    Rodrigues PM, Afonso MB, Simão AL, Islam T, Gaspar MM, O'Rourke CJ, Lewinska M, Andersen JB, Arretxe E, Alonso C, Santos-Laso Á, Izquierdo-Sanchez L, Jimenez-Agüero R, Eizaguirre E, Bujanda L, Pareja MJ, Prip-Buus C, Banales JM, Rodrigues CMP, Castro RE. Rodrigues PM, et al. Liver Int. 2023 Oct;43(10):2256-2274. doi: 10.1111/liv.15682. Epub 2023 Aug 3. Liver Int. 2023. PMID: 37534739

References

REFERENCES

    1. Liu J, Ayada I, Zhang X, et al. Estimating global prevalence of metabolic dysfunction-associated fatty liver disease in overweight or obese adults. Clin Gastroenterol Hepatol. 2022;20:e573-e582.
    1. Huang DQ, El-Serag HB, Loomba R. Global epidemiology of NAFLD related HCC: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol. 2021;18:223-238.
    1. Wu J, Nagy LE, Liangpunsakul S, Wang L. Non-coding RNA crosstalk with nuclear receptors in liver disease. Biochim Biophys Acta Mol Basis Dis. 2021;1867(5):166083.
    1. Agbu P, Carthew RW. MicroRNA-mediated regulation of glucose and lipid metabolism. Nat Rev Mol Cell Biol. 2021;22(6):425-438.
    1. Wang X, He Y, Mackowiak B, Gao B. MicroRNAs as regulators, biomarkers and therapeutic targets in liver diseases. Gut. 2021;70(4):784-795.

LinkOut - more resources